Glenn N. Saxe
Director of the The Child Study Center at NYU Langone Medical Center
New York University
From this contributor
The urgent need to shorten autism’s diagnostic odyssey
With the rate of autism now at 1 in 68 people and climbing, the need for solutions that reach the risk population more quickly and effectively has never been more real, say Dennis Wall and Glenn Saxe.
The urgent need to shorten autism’s diagnostic odyssey
Explore more from The Transmitter
Imagining the ultimate systems neuroscience paper
A growing body of papers on systems neuroscience and on giant simulations of neural circuits involves data beyond the point that anyone can reasonably understand end to end. Looking ahead, “paper-bots” could solve that problem.
Imagining the ultimate systems neuroscience paper
A growing body of papers on systems neuroscience and on giant simulations of neural circuits involves data beyond the point that anyone can reasonably understand end to end. Looking ahead, “paper-bots” could solve that problem.
This paper changed my life: ‘Histone demethylation mediated by the nuclear amine oxidase homolog LSD1,’ from the Shi Lab
This paper defined key rules of epigenomic regulation and shaped how I study chromatin plasticity as a mechanism for experience-dependent changes in the brain.
This paper changed my life: ‘Histone demethylation mediated by the nuclear amine oxidase homolog LSD1,’ from the Shi Lab
This paper defined key rules of epigenomic regulation and shaped how I study chromatin plasticity as a mechanism for experience-dependent changes in the brain.
What’s next for brain-directed gene therapy after death in Neurogene trial
The incident highlights that viral vectors can trigger deadly immune responses even when delivered directly to the nervous system.
What’s next for brain-directed gene therapy after death in Neurogene trial
The incident highlights that viral vectors can trigger deadly immune responses even when delivered directly to the nervous system.